Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents

The PTA N-alkyl
derivatives (PTAC2H4OCOMe)­X (1X: 1a, X = Br; 1b, X = I; 1c, X = PF6; 1d, X = BPh4), (PTACH2COOEt)­X (2X: 2a, X = Br; 2b, X = Cl; 2c, X = PF6), and (PTACH2CH2COOEt)­X (3X: 3a, X = Br; 3c, X = PF6), presenting all the functional groups
of the natural cationic compounds acetylcholine or trimethylglycine
combined with a P-donor site suitable for metal ion coordination,
were prepared and characterized by NMR, ESI-MS, and elemental analysis.
The X-ray crystal structures of 1d and 2c were determined. Ligands 1c, 2b, and 3c were coordinated to Pt­(II) and Ru­(II) to give the cationic
complexes cis-[PtCl2(L)2]­X2 and [RuCpCl­(PPh3)­(L)]­X (L = 1, 2, 3, X = Cl or PF6) designed with a structure targeted for
anticancer activity. The X-ray crystal structure of [CpRu­(PPh3)­(PTAC2H4OCOMe)­Cl]­PF6 (1cRu) was determined. The antiproliferative
activity of the ligands and the complexes was evaluated on three human
cancer cell lines.